LIVE Price Database Suppliers B2B suppliers Quality & badges Encyclopedia Articles
LONGEVITY TOPICS
NAD+ Precursors Sirtuin Activators Senolytics Autophagy Mitochondrial Hormesis
About PeptideCompare Business Network Contact Policy
Home / Encyclopedia / Khavinson Bioregulators / Bolamin
MONOGRAPH No. 046
EVIDENCE BASELimited
TYPE
Natural peptide complex (cytomedin)
SEQUENCE
Proprietary complex
CAS
Not assigned
EU STATUS
Research only
WADA
Not listed
MIN PURITY
Lab-specific
Khavinson Bioregulators

Bolamin — EU research guide.

Bolamin is a Khavinson-series peptide bioregulator formulated for the bone marrow, proposed to support hematopoiesis and bone marrow stem cell function in aging models. It is one of the lesser-documented entries in the same research family as Thymalin and Vilon.

Last reviewed:

What is Bolamin?

Bolamin is a Khavinson-series peptide bioregulator formulated for the bone marrow, proposed to support hematopoiesis and bone marrow stem cell function in aging models. It is one of the lesser-documented entries in the same research family as Thymalin and Vilon.

What does the research show?

Published data is sparse even by the standards of this research family: no animal or human study under the name Bolamin was found in the sources checked. No independently replicated controlled trials are publicly available as of mid-2026.

EU legal status

Not approved as a medicine anywhere in the EU. Available only from a very small number of specialist research vendors.

⚠ Among the least independently documented compounds in this guide series — treat any specific efficacy claims with significant caution until better-quality evidence exists.
✓ Not yet tracked in PeptideCompare's price comparison. Verify any vendor's COA and sequence/identity claims directly before ordering — see our COA guide.
EVIDENCE SUMMARY
NO HUMAN DATA
No data found under this name — No human study of Bolamin was found, and no animal study either. The name appears on peptide-vendor and aggregator lists, but not in the Khavinson-group publications checked. The bone marrow product in the group's commercial catalogue is sold as Bonomarlot, so Bolamin may be a vendor label or a mislabelled name; this could not be resolved.
LIMITED
Bone marrow bioregulators in the group's reviews — The group's 2013 review of animal work lists peptide preparations isolated from tissues including bone marrow, but its detail is on thymus, pineal and brain preparations. The page's statement of small animal studies on hematopoietic markers could not be confirmed. The 2014 review of clinical trials covers seven other preparations and none from bone marrow.

Molecular information

CAS number
Not assigned

Pharmacokinetics

No established human pharmacokinetic data. Published human PK parameters for this compound are not available; reported data are limited to animal models or absent. No curve is shown, to avoid implying data that does not exist.

Potency retained over time

Each line is one storage condition: it starts at 100% and falls as potency is lost. Above the dashed 80% line the material is considered reliable — hover for exact values.

Freezer −20 °C
36+ mo
Stable · >95% potency
Fridge 4 °C
3-4 mo
In use · after recon
Room 20 °C
10-13 days
Limited · moderate loss
Warm 37 °C+
2-3 days
Critical · rapid degradation

⚠ Modelled per compound from molecular structure — chain length, cyclisation, oxidation- and deamidation-prone residues and light sensitivity. Indicative only, not lab-measured per batch.

Bolamin is not yet in our price comparison

We expand EU supplier coverage every month.

References

  1. Group review of animal studies on peptide bioregulators. It mentions preparations from bone marrow among many tissues but gives no data specific to a product called Bolamin; all data come from the originating group. Khavinson VKh, Kuznik BI, Ryzhak GA. Peptide bioregulators: a new class of geroprotectors. Message 1: Results of experimental studies. Adv Gerontol. 2013;3(3):225-235. DOI
  2. Group review of clinical trials of seven peptide bioregulators. No bone marrow preparation is among them, so it provides no human evidence for this compound; it is also written by the developers. Khavinson VKh, Kuznik BI, Ryzhak GA. Peptide bioregulators: a new class of geroprotectors. Report 2: The results of clinical trials. Adv Gerontol. 2014;4(4):346-361. DOI

Related guides

Khavinson Bioregulators

Bronchogen
Khavinson Bioregulators

Cardiogen
Khavinson Bioregulators

Cartalax
PeptideCompare AssistantOnline · replies instantly
Hi! I help you quickly find the right page — about legality, COAs, badges or suppliers. No price advice, no dosing.
Try a question
Find a supplier Questions about a peptide? Read our articles Compare prices Is this legal in the EU? How to read a COA What do badges mean? Will customs stop my order? What is BAC water? Talk to a doctor first?
Navigation assistant · no medical advice